Company: BIAF
Filing Date: 2025-06-27
Form Type: POS AM
Source: 0001641172-25-016923
Chunk: 182

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-06-27
Form: POS AM
Chunk 182
---
|:----|:-----------------|-----:|:----|:----------------------|-----:|:----|:----------------|:--|
| Outstanding at December 31, 2024         |     |           | 304,125 |     | $                | 6.95 |     |                       | 4.45 |     |                 | — |
| Granted                                  |     |           |       — |     |                  |    — |     |                       |    — |     |                 | — |
| Exercised                                |     |           |       — |     |                  |    — |     |                       |    — |     |                 | — |
| Forfeited                                |     |           |       — |     |                  |    — |     |                       |    — |     |                 | — |
| Outstanding at March 31, 2025            |     |           | 304,125 |     | $                | 6.95 |     |                       | 4.20 |     |                 | — |
| Vested and exercisable at March 31, 2025 |     |           | 304,125 |     | $                | 6.95 |     |                       | 4.20 |     |                 | — |

| F-13 |

As of March 31, 2025, there was no
unrecognized compensation cost related to non-vested stock options.

The
following table summarizes restricted stock award activity under the 2014 Plan and 2024 Plan:

SUMMARY OF RESTRICTED STOCK AWARD

|                              |     | Number of    |           |   |     |             |      |     |            |           |   |     | As of March 31, 2025 |           |     |          |         |   |
|:-----------------------------|:----|:-------------|----------:|:--|:----|:------------|-----:|:----|:-----------|----------:|:--|:----|:---------------------|----------:|:----|:---------|--------:|:--|
|                              |     | restricted   
 stock awards 
 (RSA)        |           |   |     | Weighted-   
 average     
 grant price |      |     | FMV on     
 grant date |           |   |     | Vested               
 number               
 of RSA               |           |     | Unvested 
 number   
 of RSA   |         |